Rydapt Coupons & Savings Card – Discount Prices from $489.18
My prescription
Edit
25MG, Rydapt (2 Capsules)
Select pharmacy
Walgreens
$489.18
COUPON PRICE
Albertsons
$500.05
COUPON PRICE
Walmart
$504.68
COUPON PRICERydapt savings card
Show this card to your pharmacistWalgreens
$489.18
BIN
ID
PCN
GRP
019876
LH74368326
CHIPPO
LHX
Powered by
Related kinase inhibitors prescriptions
More prescriptions for leukemia
Related kinase inhibitors prescriptions
More prescriptions for leukemia
Price history for Rydapt
2 Capsules, 25MG
Average retail price for Rydapt
Average SaveHealth price for Rydapt
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Rydapt dosage forms
Dosage Quantity Price from Per unit 25MG 2 Capsules $489.18 $244.59 25MG 28 Capsules $6,928.30 $247.44 25MG 56 Capsules $13,848.59 $247.30 25MG 112 Capsules $27,689.18 $247.23
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 25MG | 2 Capsules | $489.18 | $244.59 |
| 25MG | 28 Capsules | $6,928.30 | $247.44 |
| 25MG | 56 Capsules | $13,848.59 | $247.30 |
| 25MG | 112 Capsules | $27,689.18 | $247.23 |
How does Rydapt work?
Rydapt (midostaurin) works by inhibiting multiple kinases, including FLT3 and KIT, which are involved in the signaling pathways that regulate cell growth and survival. By blocking these kinases, Rydapt helps to slow down or stop the growth of cancer cells, particularly in conditions like acute myeloid leukemia (AML) with FLT3 mutations and systemic mastocytosis.
Is midostaurin a chemo drug?
Yes, midostaurin is considered a type of chemotherapy drug. It is a targeted therapy used to treat certain types of cancer, such as acute myeloid leukemia (AML) and advanced systemic mastocytosis.
What is the indication for Rydapt?
Rydapt is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a FLT3 mutation, as detected by an FDA-approved test. It is also indicated for the treatment of adults with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
What is the route of administration for Rydapt?
Rydapt is administered orally.
What type of drug is midostaurin?
Midostaurin is a type of medication known as a kinase inhibitor. It is used primarily in the treatment of certain types of cancer, such as acute myeloid leukemia (AML) with a specific genetic mutation and advanced systemic mastocytosis.